WO2004081203A1 - Extraction and use of collagen extracted from either a sea mammal or a bony fish - Google Patents

Extraction and use of collagen extracted from either a sea mammal or a bony fish Download PDF

Info

Publication number
WO2004081203A1
WO2004081203A1 PCT/CA2004/000377 CA2004000377W WO2004081203A1 WO 2004081203 A1 WO2004081203 A1 WO 2004081203A1 CA 2004000377 W CA2004000377 W CA 2004000377W WO 2004081203 A1 WO2004081203 A1 WO 2004081203A1
Authority
WO
WIPO (PCT)
Prior art keywords
collagen
cells
improvement
extracted
bony fish
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/CA2004/000377
Other languages
French (fr)
Inventor
Adrien Beaudoin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIOCEAN NOVATECH Inc
Original Assignee
BIOCEAN NOVATECH Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIOCEAN NOVATECH Inc filed Critical BIOCEAN NOVATECH Inc
Priority to EP04718892A priority Critical patent/EP1601762A1/en
Priority to JP2006504075A priority patent/JP2006519790A/en
Priority to US10/548,520 priority patent/US20070081961A1/en
Priority to CA002518905A priority patent/CA2518905A1/en
Publication of WO2004081203A1 publication Critical patent/WO2004081203A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
    • C12N5/0629—Keratinocytes; Whole skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0062—General methods for three-dimensional culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0068—General culture methods using substrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/54—Collagen; Gelatin

Definitions

  • the present invention relates to the extraction and use of collagen and more
  • Collagen is the most abundant protein in mammals. Apart from water it is the nest
  • proteoglycans the extracellular matrix.
  • the composition of the latter varies from tissue to
  • tissue For example there is less elastin relative to collagen in the skin as compared to
  • cow disease (Creutfeld- Jacob Disease), and many types of animal viruses (including those
  • Collagen is a family of fibrous proteins comprising more
  • Types are variations on a common theme with a basic
  • Type I found in all the tissues, and more particularly the skin, tendons, bones,
  • Type II found in cartilage, intervertebral discs, and vitreous bodies.
  • Type III found in the cardiovascular system and conjunctive tissues of the
  • stroma including fetal skin.
  • Type V found in the placenta, aminos, and chorion.
  • Type I collagen tends to increase the cell attachment and the spreading on the flask
  • Type I also affects the adhesion and cell morphology and increases cell viability.
  • Type III collagens are known to increase cell attachment and modify the cell
  • Type IV favors cell attachment whereas the type V increases the proliferation of the
  • Collagen molecules can be solubilized while keeping some intermolecular bounds.
  • Tropocollagen has a molecular mass of 285 kDa .
  • Type I collagen is a heterotrimer
  • the glycine-proline-hydroxyproline sequence is repetitive.
  • collagen matrix are much more expensive than those covered with a polymer. In most cases
  • collagen from seal skin and collagen from salmon are proposed as a
  • a cell-free bottom layer of collagen is usually placed in the culture flask to prevent attachment to the surface of the culture vessel.
  • a top layer containing the cell is then placed
  • epithelial cells e.g., hepatocytes, mammary epithelial cells, colonic epithelial cells,
  • keratinocytes some mesenchymal cells (e.g. endothelial cells) and neurons.
  • mesenchymal cells e.g. endothelial cells
  • neurons e.g. endothelial cells
  • collagen substrate is primordial to keep the integrity of stem cells.
  • the collagens of the present of the present invention are surprising in that they are
  • the collagens produced according to the present invention can also be used in any other organ.
  • the collagen of the present invention would assist in the growing of the cells as will be
  • seals are a furry salt water mammal and which have never
  • the collagen would preferably be coated on the surface thereof.
  • collagen has a great affinity for water and can act as an emulsifier.
  • the collagen as derived from a marine mammal
  • Flasks were maintained for 20 minutes under the UV light in a laminar flow hood under UV light
  • Figure 1 shows an electro phosphorus of the collagens extracted from salmon skins
  • Figure 2 shows the cells of human skin without a matrix
  • Figure 3 illustrates cells of human skin cultivated without an extra cellular matrix
  • Figure 4 illustrates the growth of human skin cells utilizing seal collagen
  • Figure 5 shows the growth of human skin cells in a commercial collagen coated flask
  • Figure 6 illustrates of growth of human skin cells on a matrix of collagen derived
  • Collagens are highly sensitive to pH variations. Seal collagen precipitates around pH 4.7, whereas salmon collagen precipitates between 4.32 - 5.26. Table 2
  • Ionic strength is another factor that influences collagen solubility.
  • Our results show a large variation in the NaCl concentration required to precipitate seal collagen as compared to salmon collagen. Results have been determined by two different methods, spectroscopy or by precipitate formation after centrifugastion. By spectroscopy, salmon collagen does not show a clear turn point, whereas seal collagen does. Salmon skin collagen requires a higher concentation of salt to precipitate, 0.647 M seal skin collagen precipitates at 0.152 M of NaCl
  • Collagen is soluble in liquid solution at low pH and salt concentration.
  • the collagen was extracted as follows:
  • bovine serum (Sigma Chem. Co. St-Louis Mo USA).
  • HUVEC ATCC CRL 1730 HUVEC ATCC CRL 1730. In the latter case heparin and endothelial cell growth
  • seal collagen can support the proliferation of
  • epethetical cells like keratinocytes and endothelia cells in vitro and exhibits properties

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cosmetics (AREA)

Abstract

A process for a cell culture wherein the cells are grown on a substrate, the improvement comprising the step of growing the cells on collagen substrate with the collagen having been extracted from an animal selected from the group consisting of a marine mamal and a bony fish. Preferred embodiments include those wherein the collage is either from salmon or a seal.

Description

EXTRACTION AND USE OF COLLAGEN EXTRACTED FROM EITHER A SEA MAMMAL OR A BONY FISH
FIELD OF THE INVENTION
The present invention relates to the extraction and use of collagen and more
particularly, relates to the extraction and use of collagen extracted from either a sea mammal
or a bony fish.
BACKGROUND OF THE INVENTION
Collagen is the most abundant protein in mammals. Apart from water it is the nest
major constituent of skin, cartilagineous tissues, blood vessels and teeth. It is generally
found around the cells in tissues, forming with other proteins such as elastin and
proteoglycans, the extracellular matrix. The composition of the latter varies from tissue to
tissue. For example there is less elastin relative to collagen in the skin as compared to
tendons where elastin is very important. The extracellular matrix exerts profound influences
on many aspects of cell life, including morphology, differentiation and genetic expression,
adhesion and proliferation. It is noteworthy that in the course of the aging process the
extracellular matrix is considerably modified. It is well known that corporations in the
cosmetic industry have taken advantage of the rejuvenating properties of collagen, in
manufacturing and marketing of their products. Use of collagen can include in vitro cell
culture, medical devices, cosmetic dermatological uses, etc.
In the past few years the use of collagens derived from bovine, porcine and aviary
sources has become problematic especially with the appearance of prions in the case of mad
cow disease (Creutfeld- Jacob Disease), and many types of animal viruses (including those
closely related to SARS and potentially transmissible to humans). The need for alternative sources of collagen is pressing. Collagen is a family of fibrous proteins comprising more
than 12 different Types. These Types are variations on a common theme with a basic
structural similarity.
The most common types are:
Type I found in all the tissues, and more particularly the skin, tendons, bones,
and cornea.
Type II found in cartilage, intervertebral discs, and vitreous bodies.
Type III found in the cardiovascular system and conjunctive tissues of the
stroma, including fetal skin.
Type IV found in the basal membrane, the sub-adjacent basal membrane of
endothelial cells and surrounding muscle tissues.
Type V found in the placenta, aminos, and chorion.
Different types of collagen, when used in cell culture, have somewhat different roles.
Thus, Type I collagen tends to increase the cell attachment and the spreading on the flask
surface, stimulates cells proliferation and allows the experimenter to use less serum in the
medium. Type I also affects the adhesion and cell morphology and increases cell viability.
Type III collagens are known to increase cell attachment and modify the cell
behavior.
Type IV favors cell attachment whereas the type V increases the proliferation of the
cells and specifically endothelial cells.
For a more detailed analysis on the properties of the different types of collagen, one
may refer to: Kuhn K (1987) The classical collagens: Type I, II, and III in Structure and
Function of collagen Types ( R. Mayne and R. E. Burgeson, eds) Academic Press NY p.l. Collagen exists in three states:
i) Fibrous state, as in tendons;
ii) Cristalline state or tropocollagen;
iii) Denatured state as in gelatins.
Collagen molecules can be solubilized while keeping some intermolecular bounds.
In 1955 Gallop P. M. (Arch.Biochem and Biophys.: 54.486-495) has isolated and partially
characterized ichtyocol or fish collagen. He found that heating at 30°C changed optical
rotation - 110° in two hours. He also noticed that molecular weight and viscosity were
reduced. It was later found that the molecule was comprised of three helicoidal chains of
about 100000 daltons forming the monomer and that the monomer was quickly denatured
when temperature was raised explaining the reduction of viscosity. The absence of cross-
linking between chains in the immature collagen allowed later the isolation and
characterization of its basic structural unit, i.e. tropocollagen.
Tropocollagen has a molecular mass of 285 kDa . Type I collagen is a heterotrimer
comprising two alpha- 1 chains and another chain termed alpha-2. The other types of
collagen have three identical chains, each one of them is comprised of about one thousand
amino acids for a molecular mass of 285 kDa. The proportion of glycine residues is very
high (one third). One finds also the highest proportion of proline encountered in any other
known proteins. Finally two unusual amino acids are present, hydroxyproline and
hydroxylysine. The glycine-proline-hydroxyproline sequence is repetitive.
Analysis of skin collagen Type 1 from the rainbow trout, a species belonging to the
salmonoid family, revealed an unusual composition. Indeed collagens were found to be
made of trimers of alpha- 1, alpha-2, alpha-3, and 2 alpha- 1 and 1 alpha-3 chains respectively. The occurrence of alpha-3 has been observed in bony fish only. The lower
stability of these fish collagens seems to be related to the fact that there is a small number of
Gly-Pro-Pro triplets and a large number Gly-Gly doublets thereby loosening the triple-
helical structure.
(Ref: M. Saito, Y. Takenouchi, N. Kunisaki, S. Kimura)
Complete primary structure of rainbow trout type I collagen consisting of al(l) a2(l) a3(l)
heterotrimers European Journal of Biochemistry : 268(10) p 2817, May 2001
Some animal cells can be grown in suspension whereas others require an extracellular
matrix to survive. Absence of such a layer for the latter type of adhering cells results in the
loss of their morphological characteristics and eventually death.
On the market one finds two types of surface (flasks) on which cells adhere
i) Charged electrostatic polymer
ii) Collagen matrix
If one refers to the commonly available products, one finds that flasks covered with a
collagen matrix are much more expensive than those covered with a polymer. In most cases
it is more appropriate to use a collagen matrix than these polymers which are artificial to the
cell. In this invention collagen from seal skin and collagen from salmon are proposed as a
cell matrix for cell culture.
There are three different approaches commonly used to cultivate cells on a collagen
matrix
1. On top of a collagen layer
2. Embedded in a collagen gel layer for three-dimensional culture. In
this case, a cell-free bottom layer of collagen is usually placed in the culture flask to prevent attachment to the surface of the culture vessel. A top layer containing the cell is then placed
on the bottom layer.
3. Between two collagen layers.
Cells which are routinely grown on collagen-coated surfaces, or collagen gels, include
epithelial cells (e.g., hepatocytes, mammary epithelial cells, colonic epithelial cells,
keratinocytes), some mesenchymal cells (e.g. endothelial cells) and neurons. The need for a
collagen substrate is primordial to keep the integrity of stem cells.
The collagens of the present of the present invention are surprising in that they are
ideally suited for cell culture as well as a number of other uses. Thus, it has typically been
such in the industry, that, for cell culture, a membrane of gelatin must first be provided and
which membrane is then coated with the collagen. The collagens extracted according to the
present invention do not require such a membrane, but rather can be directly used on a flask
or other substrate for the cell culture.
The collagens produced according to the present invention can also be used in
medical devices. Thus, many such medical devices are implanted in the body and the use of
the collagen of the present invention would assist in the growing of the cells as will be
shown hereinbelow. Furthermore, the collagen derived from a seal does not carry any
known risk of infection. Thus, seals are a furry salt water mammal and which have never
been known to carry any infectious diseases.
In medical devices, the collagen would preferably be coated on the surface thereof.
Indeed, it can even be used with medical sutures.
A further use of the collagens of the present invention would be for dermatological
applications. As will be demonstrated hereinbelow, collagen has a great affinity for water and can act as an emulsifier.
In addition to the above, the collagens of the present invention could also be used, in
admixture, with other components which may be injected into the body. Thus, for example,
it could readily be utilized in the case of broken bones.
Thus, as may be seen from the above, the collagen as derived from a marine mammal
and in particular from a seal, shows excellent properties for cell culture. A salmon based
collagen likewise shows interesting properties.
Protocol for cell culture
A. Flasks treated covered with collagene I (Biocoat collagen cell ware flasks) No. Cat 354531, BD Biosciences (Rat tail tendon) Falcon flasks without matrix Flasks covered with salmon skin collagen Flasks covered with seal skin collagen
Adhering cells (B J=epithelial cells from human prepuce (ATCC) Endothelial cells from human umbilical vein Culture medium + fetal beef serum + trypsine.
B. Coating of culture flasks with collagen
2 ml of the experimental collagen was mixed with 2 ml of culture medium
A whitish precipitate formed which was evenly spread with a Q-tip on the flask bottom
Flasks were maintained for 20 minutes under the UV light in a laminar flow hood under UV light
About 2 million cells / 10 ml were introduced in each flask incubation temperature was 37°C. Under (95% 02 / 5% C02) atmosphere BRIEF DESCRIPTION OF THE DRAWINGS
In the drawings;
Figure 1 shows an electro phosphorus of the collagens extracted from salmon skins
and seal skins compared with other collagens.
Figure 2 shows the cells of human skin without a matrix;
Figure 3 illustrates cells of human skin cultivated without an extra cellular matrix;
Figure 4 illustrates the growth of human skin cells utilizing seal collagen;
Figure 5 shows the growth of human skin cells in a commercial collagen coated flask;
and
Figure 6 illustrates of growth of human skin cells on a matrix of collagen derived
from salmon skin.
DESCRIPTION OF THE PREFERRED EMBODIMENTS
Table 1
Influence of pH on solubility offish and seal skin collagen
Figure imgf000008_0001
Collagens are highly sensitive to pH variations. Seal collagen precipitates around pH 4.7, whereas salmon collagen precipitates between 4.32 - 5.26. Table 2
Influence of ionic strength on collagen solubility offish and seal skins.
Figure imgf000009_0001
Ionic strength is another factor that influences collagen solubility. Our results show a large variation in the NaCl concentration required to precipitate seal collagen as compared to salmon collagen. Results have been determined by two different methods, spectroscopy or by precipitate formation after centrifugastion. By spectroscopy, salmon collagen does not show a clear turn point, whereas seal collagen does. Salmon skin collagen requires a higher concentation of salt to precipitate, 0.647 M seal skin collagen precipitates at 0.152 M of NaCl
Table 3
Water content of seal collagen.(hydration)
Figure imgf000009_0002
Experiment 3. Was carried by lyophilisation instead of drying in section. The two techniques gave comparable results and shows that seal collagen absorbs approximately 98% water. The procedure of collagen extraction from seal and fish skins was adapted from the
method of Elsdale and Bard (Ref. Elsdale, T.s Bard, J. (1972) Collagen substrata for studies
on cell behaviour. J. Cel Biol. 54: 626-634) as described in the Second Edition of the
"Culture of Animal Cells" by Ian R. Freshney, Edited by Alan R. Lis Inc., New York.
Collagen is soluble in liquid solution at low pH and salt concentration. Increasing the
pH to 7.4 and increasing the ionic strength causes the collagen to gel.
The collagen was extracted as follows:
Materials
10X BME (Eagle Basal Medium)
7,5% solution of sodium bicarbonate
L-glutamine (200mM)
Fetal calf serum
Nanopure water
0,142 M NaOH
0,5 M acetic acid
In Figure 1 proteins were separated by sodium dodecylsufate polyacrylamide gel
electrophoresis according to Laemmli (ref. Laemmli U K Cleavage of Structural Prόeteins
During the Assembly of the Head of Bacteriophage T4. Nature 227,680-685)
In Figure 2, the cells were cultured in F12K medium supplemented with 10% fetal
bovine serum (Sigma Chem. Co. St-Louis Mo USA).
A similar culture medium was used for the experiments illustrated in Figures 3 to 6.
As may be seen from the figures, one can note that without a matrix of collagen, there
is a lot of cellular debris and cells do not adhere to the flask. In Figures 4 and 6, which
represent the cells grown using seal collagen and salmon collagen respectively, it will be
noted the cells adhere well to the matrix and there is very little cellular debris. On the other hand, with those cells grown in a flask with commercial collagen,
it will be noted that the growth appears to be slower than the previous examples.
Essentially similar results were obtained with human umbilical vein endothelial cells
HUVEC ATCC CRL 1730. In the latter case heparin and endothelial cell growth
supplement (from Sigma Chem Co.) Were added to the culture medium.
From the above, it will be seen that seal collagen can support the proliferation of
epethetical cells like keratinocytes and endothelia cells in vitro and exhibits properties
compatible with its use in medical devices. In particular, such medical devices can be mixed
with the collagen.

Claims

I CLAIM:
1. In a cell culture process wherein cells are grown on a substrate, the improvement
comprising the step of growing said cells on a collagen substrate, said collagen being
extracted from an animal selected from the group consisting of a marine mammal and a bony
fish.
2. The improvement of claim 1 wherein said collagen is extracted from a marine
mammal.
3. The improvement of claim 2 wherein said marine mammal is a seal.
4. The improvement of claim 3 wherein said collagen is a type 1 collagen.
5. The improvement of claim 1 wherein said collagen is extracted from a bony
fish.
6. The improvement of claim 5 wherein said bony fish is salmon.
7. The improvement of claim 1 wherein said cells are cultivated mammalian
cells.
8. The improvement of claim 7 wherein said cultivated mammalian cells are
epithelial cells.
9. The improvement of claim 8 wherein said epithelial cells are keratinocytes.
10. In a container for the cultivation of cells, and wherein said container is at
least partially coated with a collagen, the improvement wherein, said collagen is selected
from a group consisting of collagens extracted from a sea mammal or a bony fish.
11. In a dermatological product, the improvement wherein said product contains
collagen extracted from an animal selected from the group consisting of collagens extracted
from sea mammals and a bony fish sea mammals and a bony fish.
12. Collagen when extracted from an animal selected from the group consisting of a
marine mammal and a bony fish.
PCT/CA2004/000377 2003-03-10 2004-03-10 Extraction and use of collagen extracted from either a sea mammal or a bony fish Ceased WO2004081203A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP04718892A EP1601762A1 (en) 2003-03-10 2004-03-10 Extraction and use of collagen extracted from either a sea mammal or a bony fish
JP2006504075A JP2006519790A (en) 2003-03-10 2004-03-10 Extraction and use of collagen extracted from either marine mammals or teleosts
US10/548,520 US20070081961A1 (en) 2003-03-10 2004-03-10 Extraction and use of collagen extracted from either a sea mammal or a bony fish
CA002518905A CA2518905A1 (en) 2003-03-10 2004-03-10 Extraction and use of collagen extracted from either a sea mammal or a bony fish

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002422906A CA2422906A1 (en) 2003-03-10 2003-03-10 Fish and seal collagens as cell matrices for cell culture
CA2,422,906 2003-03-10

Publications (1)

Publication Number Publication Date
WO2004081203A1 true WO2004081203A1 (en) 2004-09-23

Family

ID=32932272

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CA2004/000377 Ceased WO2004081203A1 (en) 2003-03-10 2004-03-10 Extraction and use of collagen extracted from either a sea mammal or a bony fish

Country Status (5)

Country Link
US (1) US20070081961A1 (en)
EP (1) EP1601762A1 (en)
JP (1) JP2006519790A (en)
CA (1) CA2422906A1 (en)
WO (1) WO2004081203A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5692770B2 (en) * 2009-02-26 2015-04-01 多木化学株式会社 Cell culture substrate
KR101209912B1 (en) * 2009-12-02 2012-12-10 한국식품연구원 Method of isolation of collagen and collagen isolated by thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5945101A (en) * 1993-03-17 1999-08-31 Berg; Richard A. Skin model system
US6271350B1 (en) * 1998-08-11 2001-08-07 Thara & Company Ltd. Fish collagen and method of producing same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5945101A (en) * 1993-03-17 1999-08-31 Berg; Richard A. Skin model system
US6271350B1 (en) * 1998-08-11 2001-08-07 Thara & Company Ltd. Fish collagen and method of producing same

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
KANEKO YUKIKO ET AL: "Effects of fish and calf type I collagens as culture substrate in the adhesion and spreading process of established fish cells", IN VITRO CELLULAR AND DEVELOPMENTAL BIOLOGY ANIMAL, vol. 31, no. 3, 1995, pages 178 - 182, XP009032911, ISSN: 1071-2690 *
NOMURA YOSHIHIRO ET AL: "Use of shark collagen for cell culture and zymography.", BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, vol. 66, no. 12, December 2002 (2002-12-01), pages 2673 - 2676, XP002286324, ISSN: 0916-8451 *
SUMMERS G W ET AL: "Amino-acid composition of collagen isolated from the oral cavity of the sperm whale.", NATURE. ENGLAND 5 JUN 1965, vol. 206, no. 988, 5 June 1965 (1965-06-05), pages 1046 - 1047, XP009033151, ISSN: 0028-0836 *

Also Published As

Publication number Publication date
JP2006519790A (en) 2006-08-31
CA2422906A1 (en) 2004-09-10
US20070081961A1 (en) 2007-04-12
EP1601762A1 (en) 2005-12-07

Similar Documents

Publication Publication Date Title
El Blidi et al. Extraction methods, characterization and biomedical applications of collagen: A review
Olsen et al. Recombinant collagen and gelatin for drug delivery
Lillie et al. Fine structure of subcultivated stratified squamous epithelium grown on collagen rafts
EP1509546B1 (en) Method for producing collagen
CA2321117C (en) Submucosa gel compositions
JP6120428B2 (en) Differentiation-inducing composition
JPWO2015167003A1 (en) Collagen or atelocollagen degradation product, method for producing the degradation product, and use of the degradation product
US9018009B2 (en) Thermally induced gelation of collagen hydrogel and method of thermally inducing gelling a collagen hydrogel
US20070081961A1 (en) Extraction and use of collagen extracted from either a sea mammal or a bony fish
EP0759932A1 (en) Collagen from cell cultures
JPH0775566A (en) Culture of fish cell
JP5687829B2 (en) Type I-type IV collagen hybrid gel
CA2518905A1 (en) Extraction and use of collagen extracted from either a sea mammal or a bony fish
KR20230104164A (en) Collagen and/or gelatin production, isolation and/or extraction from animal cell lines and/or tissue explants
EP4097221A1 (en) Novel corneal tissues and methods of making the same
JP7587332B1 (en) Method for inducing differentiation into neural cells
Rocha et al. Unraveling the potential of Chondrosia reniformis collagen for tissue engineering scaffolds, with particular insights into chondrogenic differentiation
Sawhney Expression of type I and type III procollagen by lens epithelial cells.
CN119708205B (en) Recombinant human type VI collagen, and production method and application thereof
AU2005100078B4 (en) Collagen and method for producing same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2518905

Country of ref document: CA

Ref document number: 2006504075

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2004718892

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2004718892

Country of ref document: EP

DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2007081961

Country of ref document: US

Ref document number: 10548520

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 10548520

Country of ref document: US

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)